| Dr Samuel D Beitler, DPM | |
|
795 Aquahart Rd, #125, Glen Burnie, MD 21061-3962 | |
| (410) 768-0702 | |
| (410) 768-0649 |
| Full Name | Dr Samuel D Beitler |
|---|---|
| Gender | Male |
| Speciality | Podiatrist |
| Location | 795 Aquahart Rd, Glen Burnie, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467454843 | NPI | - | NPPES |
| 602368100 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 445 (Maryland) | Primary |
| Provider Name | Podiatry Associates Ambulatory Surgical Centers Llc |
|---|---|
| Provider Type | Part B Supplier - Ambulatory Surgical Center |
| Provider Identifiers | NPI Number: 1346308962 PECOS PAC ID: 3870849151 Enrollment ID: O20180628000845 |
News Archive
Previous studies have largely assumed that the prevalence of mental disorders declines with old age.
Allergan, Inc. announced today that the United States District Court for the District of Delaware ruled in favor of Allergan, Inc. in its patent infringement suit against Exela PharmSci, Inc., Exela PharmSci Pvt., Ltd. ("Exela"), Apotex, Inc. and Apotex Corp. ("Apotex") (collectively, the "Defendants") for seeking to market purported generic versions of Allergan's drugs ALPHAGAN® P (brimonidine tartrate ophthalmic solution) 0.1% and 0.15%. Specifically, after a trial in March of 2009, the Court ruled today that all five patents (U.S. Patent Nos. 6,627,210; 6,641,834; 6,673,337; 6,562,873; and 5,424,078) asserted by Allergan are valid and enforceable, that Apotex's proposed generic versions of ALPHAGAN® P 0.1% and 0.15% infringe each of the five patents, and that Exela's proposed generic version of ALPHAGAN® P 0.15% infringes U.S. Patent No. 6,641,834, which was the only patent asserted against it. Pursuant to the Hatch-Waxman Act, the United States Food and Drug Administration is required to delay approval of Defendants' proposed generic products until the last to expire of the infringed patents, which is 2022.
Donors at a replenishment meeting in New York on Tuesday pledged $11.7 billion over three years for the Global Fund to Fight AIDS, Tuberculosis and Malaria, "higher than past support but below the lowest target set by the agency in its efforts to combat disease in the developing world," the Financial Times reports.
The cancer death rate dropped 1.7% from 2014 to 2015, continuing a drop that began in 1991 and has reached 26%, resulting in nearly 2.4 million fewer cancer deaths during that time.
A 21 percent reduction in Medicare reimbursements that has loomed over physicians all year will go into effect on June 1, unless Congress acts to further delay the cuts, CNNMoney reports. "If the proposed cuts go through, physicians are worried their practices will be so strapped that they'll have to drop some of the 43 million Americans who are covered under Medicare."
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Samuel D Beitler, DPM 795 Aquahart Rd, #125, Glen Burnie, MD 21061-3962 Ph: (410) 768-0702 | Dr Samuel D Beitler, DPM 795 Aquahart Rd, #125, Glen Burnie, MD 21061-3962 Ph: (410) 768-0702 |
News Archive
Previous studies have largely assumed that the prevalence of mental disorders declines with old age.
Allergan, Inc. announced today that the United States District Court for the District of Delaware ruled in favor of Allergan, Inc. in its patent infringement suit against Exela PharmSci, Inc., Exela PharmSci Pvt., Ltd. ("Exela"), Apotex, Inc. and Apotex Corp. ("Apotex") (collectively, the "Defendants") for seeking to market purported generic versions of Allergan's drugs ALPHAGAN® P (brimonidine tartrate ophthalmic solution) 0.1% and 0.15%. Specifically, after a trial in March of 2009, the Court ruled today that all five patents (U.S. Patent Nos. 6,627,210; 6,641,834; 6,673,337; 6,562,873; and 5,424,078) asserted by Allergan are valid and enforceable, that Apotex's proposed generic versions of ALPHAGAN® P 0.1% and 0.15% infringe each of the five patents, and that Exela's proposed generic version of ALPHAGAN® P 0.15% infringes U.S. Patent No. 6,641,834, which was the only patent asserted against it. Pursuant to the Hatch-Waxman Act, the United States Food and Drug Administration is required to delay approval of Defendants' proposed generic products until the last to expire of the infringed patents, which is 2022.
Donors at a replenishment meeting in New York on Tuesday pledged $11.7 billion over three years for the Global Fund to Fight AIDS, Tuberculosis and Malaria, "higher than past support but below the lowest target set by the agency in its efforts to combat disease in the developing world," the Financial Times reports.
The cancer death rate dropped 1.7% from 2014 to 2015, continuing a drop that began in 1991 and has reached 26%, resulting in nearly 2.4 million fewer cancer deaths during that time.
A 21 percent reduction in Medicare reimbursements that has loomed over physicians all year will go into effect on June 1, unless Congress acts to further delay the cuts, CNNMoney reports. "If the proposed cuts go through, physicians are worried their practices will be so strapped that they'll have to drop some of the 43 million Americans who are covered under Medicare."
› Verified 3 days ago
Dr. Darlyne Cange,dpm,llc Podiatrist Medicare: Medicare Enrolled Practice Location: 7310 Ritchie Hwy Ste 404, Glen Burnie, MD 21061 Phone: 410-766-1444 | |
Dr Julian N Sober Pa Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 420 Crain Hwy S, Suite #2, Glen Burnie, MD 21061 Phone: 410-768-4300 Fax: 410-768-4301 | |
Donald Harrison, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 7671 Quarterfield Rd, Suite 302, Glen Burnie, MD 21061 Phone: 410-768-0074 Fax: 410-768-0075 | |
Dr. Eugene O Hudyma, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 7836 Oakwood Rd, Ste A, Glen Burnie, MD 21061 Phone: 410-768-6011 Fax: 410-768-6012 | |
Eugene O Hudyma Dpm Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 7836 Oakwood Rd Ste A, Glen Burnie, MD 21061 Phone: 410-768-6011 Fax: 410-768-6012 | |
Eugene Hudyma Dpm Pa Llc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 7836 Oakwood Rd Ste A, Glen Burnie, MD 21061 Phone: 410-768-6011 Fax: 410-768-6012 | |
Dr. Julian Neal Sober, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 420 Crain Hwy S, Suite #2, Glen Burnie, MD 21061 Phone: 410-768-4300 Fax: 410-768-4301 |